Anti-Inflammatory Diet Home Page...
Subscribe to Anti-Inflammatory Diet RSS feeds...
Free Anti-inflammatory diet summary... Anti-inflammation diet weight loss story... 
Home Foods to Eat Foods to Avoid Exercise Supplements Weight Loss News Diabetes News Your Concerns Archived Reports

Bookmark Us: Yahoo Simpy Technorati Email a friend Print

Eye Neoplasms
Health Information Search Results

Matching Summaries of Recent
Peer Reviewed Scientific Research Reports.

Refine Your Search:

All Words Any Words
Search Again By Year -- Simply add a space, then the year you want to your search term.

 << Prev 20  Showing 1 to 20 of 36 Matches Next 20 >>

1. The effect of screening programmes on the treatment of benign breast neoplasms: observations from current practice in Italy.
Match Strength: 6.561

PURPOSE: In the Lazio region, Italy, mammographic screening programmes were gradually activated from 1999 to 2003, providing an opportunity to compare two unselected populations in the same time period: women who were contacted in writing, and those who had not been contacted. In this study, we compare the incidences of treatments for benign and malignant neoplasms in the two groups. METHODS: The target population was women aged 50-69 years. We linked all incident cases of surgery for benign and malignant breast neoplasms, from the Hospital Information System (1999-2003) to the Mammographic ... Read More »
» Published in J Med Screen. 2006;13(3):123-8.

2. Aspects of digestive tract tumors in Down syndrome: a literature review.
Match Strength: 5.621

The purpose of this study was to describe the digestive neoplasms found in persons with Down syndrome. Due to intellectual disability, persons with Down syndrome do not convey their symptoms and pain, leading to delayed diagnosis and potentially worse outcome. It is thus important to know which organs are at risk for tumors and possible tumor risk factors. In a review of the literature, we found 13 benign tumors and 127 cancers in 1 fetus, 8 children, and 131 adults with Down syndrome. The review suggests a decreased incidence of digestive cancer, however, with a possible increased incidence ... Read More »
» Published in Dig Dis Sci. 2006 Nov;51(11):2053-61. Epub 2006 Sep 29.

3. Brenner tumors of the ovary: sonographic and computed tomographic imaging features.
Match Strength: 5.538

OBJECTIVE: The purpose of this study was to describe the sonographic appearance of ovarian Brenner tumors with computed tomographic (CT) correlation. METHODS: Twenty-two female patients (age range, 32-78 years; mean, 58 years) with 25 ovarian Brenner tumors were identified from pathologic records from 1990 to 2005. Corresponding pathologic reports and images (17 sonographic and 14 CT) were reviewed independently. RESULTS: Tumors ranged in size from 0.3 to 12 cm (mean, 2.5 cm); all were benign. Sixteen (64%) of 25 were found incidentally. Eight (36%) of 22 patients had a total of 12 associated ... Read More »
» Published in J Ultrasound Med. 2006 Oct;25(10):1245-51; quiz 1252-4.

4. Review of scalp alopecia due to a clinically unapparent or minimally apparent neoplasm (SACUMAN).
Match Strength: 4.629

Neoplastic cells, both malignant and benign, local occurring and metastatic, can cause alopecia of the scalp. However, the infiltration of neoplastic cells is sometimes not florid; a condition known as "scalp alopecia due to a clinically unapparent or minimally apparent neoplasm" (SACUMAN). Neoplastic cells can nevertheless destroy hair follicles by inducing fibroplasias via inflammatory mediators, attracting inflammatory cells and/or replacing normal cellular populations. The infiltrative nature of such an alopecia can be unapparent or only minimally apparent. The most common neoplasm in ... Read More »
» Published in Acta Derm Venereol. 2006;86(5):387-92.

5. Comparison of chronic toxicity and carcinogenicity of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in 2-year bioassays in female Sprague-Dawley rats.
Match Strength: 4.491

The cancer bioassay for 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) conducted by the Dow Chemical company in the mid 70s has been used extensively for conducting quantitative cancer risk assessments for human exposure to TCDD. More recently the National Toxicology Program (NTP) conducted a cancer bioassay of similar design as part of its evaluation of the dioxin toxic equivalency factor methodology. This report compares the design and the results of these two cancer bioassays. This comparison confirms, in most cases, previously published and widely used carcinogenic response characteristics ... Read More »
» Published in Mol Nutr Food Res. 2006 Oct;50(10):934-44.

6. Primary carcinoid tumor of the parotid gland: A case report and review of the literature.
Match Strength: 3.950

Salivary gland tumors account for 3 to 6% of all head and neck neoplasms in adults. Some 70 to 85% of these lesions are found in the parotid. Carcinoid tumors, which represent a distinct and relatively uncommon subset of neuroendocrine tumors, are most commonly found in the gastrointestinal tract, although in rare cases they are known to occur in extragastrointestinal locations, including the larynx, middle ear and pancreas. Malignancies of the parotid gland are uncommon (approximately 25% of parotid neoplasms), and to the best of our knowledge, a primary carcinoid tumor of the parotid has not ... Read More »
» Published in Ear Nose Throat J. 2006 Aug;85(8):533-9.

7. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Match Strength: 3.699

OBJECTIVE: The purpose of this study was to correlate the degree of contrast enhancement on dynamic contrast-enhanced T1-weighted MRI and the relative cerebral blood volume (rCBV) values on T2*-weighted MRI in patients with high-grade brain neoplasms. SUBJECTS AND METHODS: Ten patients with biopsy-proven high-grade gliomas underwent dynamic contrast-enhanced MRI using T1-weighted fast spoiled gradient-echo technique (TR/TE, 8.3/1.5) during i.v. infusion of 0.1 mmol/kg of MR contrast medium. This sequence was followed within 5 minutes by dynamic susceptibility contrast (DSC) imaging (1,500/80) ... Read More »
» Published in AJR Am J Roentgenol. 2006 Oct;187(4):1036-42.

8. Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions.
Match Strength: 3.340

PURPOSE: Antitumor immune response changes drastically during the progression of cancers. Established cancers often escape from the host immune system, although specific immune surveillance operates in the early stages of tumorigenesis in murine models. CD4+CD25+ regulatory T cells (TR) play a central role in self-tolerance and suppress effective antitumor immune responses. The aim of this study was to investigate the clinical significance and roles of TR in the progression and multistep carcinogenesis of pancreatic ductal adenocarcinoma. EXPERIMENTAL DESIGN: We raised anti-FOXP3 antibodies ... Read More »
» Published in Clin Cancer Res. 2006 Sep 15;12(18):5423-34.

9. Soft-tissue chondroma of the masticatory space.
Match Strength: 3.289

Soft-tissue chondroma is an infrequent, benign, cartilaginous tumour that is uncommon in the head and neck region. Single-location chondromas rarely evolve into malignant neoplasms. Chondromas are composed of hyaline cartilage with focal calcification. There have been a few reports published of cases of soft-tissue chondroma of the neck and parapharyngeal space. Here is described a new location of this tumour in the masticatory space ... Read More »
» Published in Int J Oral Maxillofac Surg. 2007 Feb;36(2):174-6. Epub 2006 Sep 27.

10. Imaging of vascular soft tissue tumors.
Match Strength: 3.147

Most tumors of the vascular system are benign, cutaneous or subcutaneous lesions that are usually readily diagnosed without significant differential diagnosis. On the other hand, lesions that arise in deep soft tissues have to be differentiated from malignant neoplasms. In these cases, further imaging work-up is necessary for local staging and planning therapy. Vascular lesions of intermediate malignancy and malignant vascular tumors are very rare and demonstrate nonspecific imaging findings. This manuscript aims to give a brief overview of vascular soft-tissue tumors and to discuss the ... Read More »
» Published in JBR-BTR. 2006 Jul-Aug;89(4):213-6.

11. Suprasellar and intrasellar paragangliomas.
Match Strength: 3.045

Neoplasms of the sellar region are entities with a large differential diagnosis. Although paraganglionic cells have not been demonstrated in the pituitary or adjacent structures, the existence of sellar region paragangliomas is well-documented. To elucidate, in this area the nature of these unusual tumors is relatively difficult. Clinical history, physical examination, radiographic investigation as well as intraoperative gross observation are the same as those of sellar meningioma or pituitary adenoma. Immunohistochemistry, using neuroendocrine markers and electron microscopy are the two ... Read More »
» Published in Clin Neuropathol. 2006 Sep-Oct;25(5):221-6.

12. Extra-osseous fat fluid level: a specific sign for osteomyelitis.
Match Strength: 3.015

Osteomyelitis may pose as a diagnostic dilemma on various imaging modalities and may be confused with neoplasms and other pathology. Although a rare finding, extra-osseous fat fluid level, especially when associated with spongy bone destruction, can be considered a specific sign of osteomyelitis. Previously, only two cases of extra-osseous fat fluid level in osteomyelitis have been reported, one on computed tomography (CT) and the other on magnetic resonance imaging (MRI). The former was a case of septic arthritis with intra-articular fat fluid level. A case of osteomyelitis is presented with ... Read More »
» Published in Skeletal Radiol. 2006 Sep 19;

13. HMGA2 rearrangement in a case of vulvar aggressive angiomyxoma.
Match Strength: 3.002

The histogenesis of aggressive angiomyxoma, an uncommon mesenchymal neoplasm of the vulvar, pelvic, and perineal soft tissues, is poorly understood, although the neoplastic cells exhibit a myofibroblastic phenotype. Cytogenetic studies of aggressive angiomyxoma are scarce; however, a nonrandom involvement of the 12q15 region where the high mobility group (HMG) protein HMGA2, an architectural transcription factor expressed primarily during embryogenesis, is located has been suggested. HMGA2 involvement has also been described in a variety of benign gynecologic mesenchymal neoplasms. We report ... Read More »
» Published in Int J Gynecol Pathol. 2006 Oct;25(4):403-7.

14. Unicameral (simple) bone cysts.
Match Strength: 2.982

Since their original description by Virchow, simple bone cysts have been studied repeatedly. Although these defects are not true neoplasms, simple bone cysts may create major structural defects of the humerus, femur, and os calcis. They are commonly discovered incidentally when x-rays are taken for other reasons or on presentation due to a pathologic fracture. Various treatment strategies have been employed, but the only reliable predictor of success of any treatment strategy is the age of the patient; those being older than 10 years of age heal their cysts at a higher rate than those under ... Read More »
» Published in South Med J. 2006 Sep;99(9):966-76.

15. From krukenberg to today: the ever present problems posed by metastatic tumors in the ovary: part I. Historical perspective, general principles, mucinous tumors including the krukenberg tumor.
Match Strength: 2.977

This review considers historical aspects of metastatic tumors to the ovary, general principles that aid in their evaluation, and metastatic mucinous tumors, including the Krukenberg tumor. The historical timeline on the Krukenberg tumor dates back to the legendary Sir James Paget and the story is followed through the well-known, albeit flawed, contribution of Friedrich Krukenberg and others who have contributed important papers over the years, including the overlooked contribution of the French investigator Gauthier-Villars. Knowledge of metastatic colorectal carcinoma is traced back to the ... Read More »
» Published in Adv Anat Pathol. 2006 Sep;13(5):205-27.

16. Incidental carcinomas in prophylactic specimens in BRCA1 and BRCA2 germ-line mutation carriers, with emphasis on fallopian tube lesions: report of 6 cases and review of the literature.
Match Strength: 2.976

The identification of germ-line mutations in 2 genes (BRCA1 and BRCA2) responsible for the majority of hereditary ovarian cancers has led an increasing number of women carriers of these mutations to undergo prophylactic oophorectomy (PO) to reduce their risk of subsequent ovarian carcinoma. A large number of unexpected, clinically occult neoplasms are thus being discovered. Up to December 2004, the Medical Genetics Service of the National Cancer Institute in Milan, Italy, has tested 756 probands from breast and/or ovarian cancer families for BRCA1 and BRCA2 germ-line mutations. Molecular ... Read More »
» Published in Am J Surg Pathol. 2006 Oct;30(10):1222-30.

17. Design, synthesis and cytotoxic properties of novel 1-[4-(2-alkylaminoethoxy)phenylcarbonyl]-3,5-bis(arylidene)-4-piperidones and related compounds.
Match Strength: 2.919

The 3,5-bis(arylidene)-4-piperidones 1 contain the 1,5-diaryl-3-oxo-1,4-pentadienyl pharmacophore which is considered to interact at a complementary binding site in susceptible neoplasms. The hypothesis was formulated that the presence of an acyl group attached to the piperidyl nitrogen atom in series 1 may interact with an additional binding site thereby enhancing cytotoxic potencies. This concept led to the synthesis of various N-acyl-3,5-bis(arylidene)-4-piperidones 3-7 many of which displayed significant cytotoxicity towards a variety of cancer cell lines. A comparison of the potencies ... Read More »
» Published in Eur J Med Chem. 2007 Jan;42(1):71-80. Epub 2006 Sep 22.

18. Imaging of an invasive malignant thymoma on PET Scan: CT and histopathologic correlation.
Match Strength: 2.821

Thymomas are common primary mediastinal neoplasms. They can be benign or malignant. The diagnosis of malignant thymomas is based on capsular invasion, cellular atypia and distant metastases. We present a case of invasive malignant thymoma as diagnosed on PET and CT scan with histologic correlation and review of literature. A seventy year old Asian man presented with cough and dyspnea. A CT scan showed an anterior mediastinal mass, and a PET scan showed a hypermetabolic mass in the corresponding location. Resection of the mass revealed a minimally invasive thymoma based on evidence of capsular ... Read More »
» Published in Clin Nucl Med. 2006 Oct;31(10):614-6.

19. Second primary oral and pharyngeal cancers in subjects diagnosed with oral and pharyngeal cancer.
Match Strength: 2.737

Patients diagnosed with oral and pharyngeal (OP) cancer have a substantial excess risk of second OP cancer, but risk quantification is still uncertain and scanty information is available on the absolute excess risk of second OP cancer. We considered the risk of second OP primary cancer in a population-based series of 3,092 first primary OP cancers registered between 1974 and 2003 in the Swiss Cantons of Vaud and Neuchatel (total population of about 786,000 inhabitants). A total of 233 second OP cancers were registered, versus 7.4 expected, corresponding to a SIR of 31.7 (95% confidence ... Read More »
» Published in Int J Cancer. 2006 Dec 1;119(11):2702-4.

20. Sellar lesions and visual loss: key concepts in neuro-ophthalmology.
Match Strength: 2.722

The pituitary gland serves an essential role in the activity and regulation of the endocrine system. Mass lesions within the pituitary gland account for approximately 10-15% of intracranial neoplasms. Patients with pituitary adenomas may present with endocrine dysfunction or neuro-ophthalmic pathology, resulting from compression of surrounding structures, most notably the optic chiasm. Visual deficits from chiasmal tumors may manifest as visual field defects, visual loss, diplopia, nystagmus and visual hallucinations. Visual field defects are the most commonly reported presenting visual ... Read More »
» Published in Expert Rev Anticancer Ther. 2006 Sep;6 Suppl 9:S23-8.

 << Prev 20  Showing results 1 to 20 of 36 Next 20 >>

* All information on is for educational purposes only. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease. Before changing your diet, or adding supplements to your diet, or beginning an exercise program, everyone should consult a qualified and licensed health practitioner; a physician, dietician or similar professional.

spacer spacer
spacer foods to eat...

Over 1,532 new health studies are published every day ― 559,288 per year. Join our weekly update program to stay informed...

» About Health Updates



Donate $5 or $10
to help us promote
anti-inflammatory health.

Bigger Font Size Smaller Font Size Left Align Justify Align Right Align Bookmark This Page
Search 3.1 Million
Health Studies

» List of 4,000+ Diseases


Subscribe to
Health Reports

Add to Google Reader or Homepage
Subscribe in NewsGator Online
Subscribe in Bloglines
Add to Excite MIX
Add to netvibes
Add to fwicki
Add to My AOL
Add to The Free Dictionary

About Us Contact Us Privacy Free Newsletter Health FAQs Terms of Use

 Subscribe in a reader

© 2010, All Rights Reserved.     Contact:

Replace omega-6 vegetable oils with omega-9 olive oil... Eat oily fish like tuna, sardines, anchovy, salmon, herring... Beans, lentils, peas add fiber... Nine or more 3-ounce servings of fruits or vegetables per day...